Randomized, double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3

AIMS: To compare the efficacy and safety of basal insulin peglispro (BIL), which has a flat pharmacokinetic and pharmacodynamic profile and a long duration of action, with insulin glargine (GL) in patients with type 1 diabetes. MATERIALS AND METHODS: In this phase III, 52‐week, blinded study, we ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergenstal, R. M., Lunt, H., Franek, E., Travert, F., Mou, J., Qu, Y., Antalis, C. J., Hartman, M. L., Rosilio, M., Jacober, S. J., Bastyr, E. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Themed Section‐bil
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096008/
https://www.ncbi.nlm.nih.gov/pubmed/27265390
http://dx.doi.org/10.1111/dom.12698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096008/
https://www.ncbi.nlm.nih.gov/pubmed/27265390
http://dx.doi.org/10.1111/dom.12698

Ejemplares similares